Siew Yen Chong, Ph.D., focuses her practice on the field of patent litigation and prosecution, as well as pre-litigation strategy counseling and freedom to operate analyses concerning application of the Biologics Act to biotherapeutic development programs. She is experienced in the design of immunogenicity and in vivo challenge studies, and development of animal models for the evaluation of pre-clinical candidate vaccines.
Her experience has included biologics and small-molecule (Hatch-Waxman) patent litigation, pre-suit investigations, opinions of counsel, IP due diligence, post-grant proceedings before the US Patent and Trademark Office, and domestic and foreign patent prosecution. Some of the technologies she has worked with include monoclonal antibodies, HIV antivirals, DNA sequencing, and other aspects of the life sciences.
Before beginning her legal career, Siew was a scientist at a multinational pharmaceutical company, where she focused on the development of candidate vaccines targeted to bacterial and viral diseases.
Bar & Court Admissions:
- New York
- New Jersey
- US District Court, Eastern District of New York
- US Patent & Trademark Office
- J.D., Rutgers University School of Law, 2010
- Ph.D., University of Medicine & Dentistry of New Jersey, 2000, Pathology and Immunology
- B.S., Upsala College, 1995, summa cum laude; co-valedictorian, Biology and Biochemistry
Rate : $$$